Results 211 to 220 of about 91,972 (285)
To the casuistry of myasthenia (myasthenia gravis)
Alida-Elizaveta G. Shuler
openalex +2 more sources
Relation Between Myasthenia Gravis and Thyroid Disease [PDF]
B. M. Sahay+2 more
openalex +1 more source
ABSTRACT Background In the Phase 3 MycarinG study (NCT03971422), rozanolixizumab improved myasthenia gravis (MG)‐specific outcomes versus placebo in patients with generalised MG, including those measured by the five independent MG Symptoms patient‐reported outcome (PRO) scales: Muscle Weakness Fatigability (MWF), Physical Fatigue (PF) and Bulbar Muscle
Henry J. Kaminski+12 more
wiley +1 more source
Efgartigimod as a Fast‐Acting Add‐On Therapy in Antibody–Mediated Autoimmune Encephalitis
ABSTRACT Background Autoimmune encephalitis (AE) is a severe neurological disorder that requires effective and safe treatment options. This study aimed to compare the efficacy and safety of intravenous methylprednisolone (IVMP) plus efgartigimod (IPE) versus IVMP alone or IVMP plus immunoglobulin (IPI) as initial treatments for antibody‐mediated AE ...
Zhuajin Bi+4 more
wiley +1 more source
Myasthenia Gravis in a Patient with Chronic Myeloid Leukemia Treated by Busulfan [PDF]
M Djaldetti+5 more
openalex +1 more source
Family Game Show-style Didactic for Teaching Nervous System Disorders during Emergency Medicine Training [PDF]
Boysen Osborn, Megan+3 more
core
Efgartigimod as Add‐On Treatment in Refractory Guillain–Barré Syndrome: A Case Report
ABSTRACT Background and Aims Guillain–Barré Syndrome (GBS) is an autoimmune disease that can cause flaccid tetraplegia. Efgartigimod, a monoclonal antibody that inhibits the neonatal receptor (FcRn), increases IgG degradation. Methods A 60‐year‐old lady was admitted with acute flaccid tetraparesis, requiring mechanical ventilation within 12 h.
P. Ripellino+6 more
wiley +1 more source
Neonatal Myasthenia Gravis [PDF]
G M Stern, J. M. Hall, Dwicht Robinson
openalex +1 more source
We review the non‐motor symptoms of MG and their potential pathogenesis, hoping to contribute to personalized diagnosis and treatment. ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder affecting the neuromuscular junction (NMJ), driven by T cells, mediated by B cells, and dependent on autoantibodies.
Benqiao Wang+3 more
wiley +1 more source
Immunological disturbances in myasthenia gravis with a report of Hashimoto's disease developing after thymectomy [PDF]
J. A. Simpson
openalex +1 more source